Menorah Medical Center is pleased to welcome Teressa Price, FNP, to the award-winning Midwest Cancer Care at Menorah. Price will work with Shalina Gupta-Burt, MD, medical oncologist and radiation oncologist and Sukumar Ethirajan, MD, oncologist in Midwest Cancer Care at Menorah.
Price earned master’s degrees in counseling from Liberty University in Lynchburg, Va., and in nursing from Graceland University in Lamoni, Iowa. She has worked in various oncology and telemetry units since 2006. She is a member of the American Nurses Association, American Association of Nurse Practitioners and the Oncology Nurses Society.
“Teressa is a welcomed addition to the Menorah Medical Center family,” says Steve Wilkinson, FACHE, president and chief executive officer of Menorah Medical Center. “She will enhance the assets we have at Midwest Cancer Care at Menorah, including the team-focused continuum of care for patients.”
“I am dedicated to my patients,” says Price. “Midwest Cancer Care at Menorah provides the utmost care, and is known for its commitment to excellence. I am honored to be part of an organization whose focus is on patient support and the compassionate care they deserve.”
Menorah Medical Center—part of HCA Midwest Health System, Kansas City’s largest healthcare network and private-sector employer—is a regional center of excellence. Midwest Cancer Care at Menorah is accredited by the American College of Surgeons Commission on Cancer as a Comprehensive Community Cancer Program and has some of the most advanced technology in the area. Menorah is the only area hospital to offer CyberKnife stereotactic radiosurgery that destroys tumors without surgery or anesthesia. In addition, The Breast Cancer of Menorah is accredited by the National Accreditation Program for Breast Centers (NAPBC), which is administered by the American College of Surgeons. Accreditation by the NAPBC is only given to those centers that have voluntarily committed to provide the highest level of quality breast care and that undergo a rigorous evaluation process and review of their performance. The world-class Sarcoma Institute, led by Howard G. Rosenthal, MD, treats patients from a wide geographic region for benign and malignant tumors of the musculoskeletal system.